BACKGROUND: Ischemic heart disease is the most common cause of mortality in diabetic patients. Although therapeutic angiogenesis is an attractive option for these patients, they appear to have reduced collateral formation in response to myocardial ischemia. The aims of this study were to establish a large animal model of diabetes and chronic myocardial ischemia, evaluate the effects of diabetes on the angiogenic response, and elucidate the molecular pathways involved. METHODS AND RESULTS: Diabetes was induced in male Yucatan miniswine using a pancreatic beta-cell specific toxin, alloxan (150 mg/kg; n=8). Age-matched swine served as controls (n=8). Eight weeks after induction, chronic ischemia was induced by ameroid constrictor placement around the circumflex coronary artery. Myocardial perfusion and function were assessed at 3 and 7 weeks after ameroid placement using isotope-labeled microspheres. Endothelial cell density and myocardial expression of angiogenic mediators was evaluated. Diabetic animals exhibited significant endothelial dysfunction. Collateral dependent perfusion and LV function were significantly impaired in diabetic animals. Diabetic animals also demonstrated reduced endothelial cell density (173+/-14 versus 234+/-23 cells/hpf, P=0.03). Expression of VEGF, Ang-1, and Tie-2 was reduced, whereas antiangiogenic proteins, angiostatin (4.4+/-0.9-fold increase, P<0.001), and endostatin (2.9+/-0.4-fold increase, P=0.03) were significantly elevated in the diabetic myocardium. CONCLUSIONS: Diabetes results in a profound impairment in the myocardial angiogenic response to chronic ischemia. Pro- and antiangiogenic mediators identified in this study offer novel targets for the modulation of the angiogenic response in diabetes.
BACKGROUND: Ischemic heart disease is the most common cause of mortality in diabeticpatients. Although therapeutic angiogenesis is an attractive option for these patients, they appear to have reduced collateral formation in response to myocardial ischemia. The aims of this study were to establish a large animal model of diabetes and chronic myocardial ischemia, evaluate the effects of diabetes on the angiogenic response, and elucidate the molecular pathways involved. METHODS AND RESULTS:Diabetes was induced in male Yucatan miniswine using a pancreatic beta-cell specific toxin, alloxan (150 mg/kg; n=8). Age-matched swine served as controls (n=8). Eight weeks after induction, chronic ischemia was induced by ameroid constrictor placement around the circumflex coronary artery. Myocardial perfusion and function were assessed at 3 and 7 weeks after ameroid placement using isotope-labeled microspheres. Endothelial cell density and myocardial expression of angiogenic mediators was evaluated. Diabetic animals exhibited significant endothelial dysfunction. Collateral dependent perfusion and LV function were significantly impaired in diabetic animals. Diabetic animals also demonstrated reduced endothelial cell density (173+/-14 versus 234+/-23 cells/hpf, P=0.03). Expression of VEGF, Ang-1, and Tie-2 was reduced, whereas antiangiogenic proteins, angiostatin (4.4+/-0.9-fold increase, P<0.001), and endostatin (2.9+/-0.4-fold increase, P=0.03) were significantly elevated in the diabetic myocardium. CONCLUSIONS:Diabetes results in a profound impairment in the myocardial angiogenic response to chronic ischemia. Pro- and antiangiogenic mediators identified in this study offer novel targets for the modulation of the angiogenic response in diabetes.
Authors: Pal Pacher; Lucas Liaudet; Francisco Garcia Soriano; Jon G Mabley; Eva Szabó; Csaba Szabó Journal: Diabetes Date: 2002-02 Impact factor: 9.461
Authors: Mitsuru Momose; Claudia Abletshauser; Jodi Neverve; Stephan G Nekolla; Oliver Schnell; Eberhard Standl; Markus Schwaiger; Frank M Bengel Journal: Eur J Nucl Med Mol Imaging Date: 2002-09-21 Impact factor: 9.236
Authors: A E Caballero; S Arora; R Saouaf; S C Lim; P Smakowski; J Y Park; G L King; F W LoGerfo; E S Horton; A Veves Journal: Diabetes Date: 1999-09 Impact factor: 9.461
Authors: Georgios I Papaioannou; Richard L Seip; Neil J Grey; Deborah Katten; Amy Taylor; Silvio E Inzucchi; Lawrence H Young; Deborah A Chyun; Janice A Davey; Frans J Th Wackers; Ami E Iskandrian; Robert E Ratner; Evelyn C Robinson; Stella Carolan; Samuel Engel; Gary V Heller Journal: Am J Cardiol Date: 2004-08-01 Impact factor: 2.778
Authors: M Tofukuji; C Metais; J Li; M D Hariawala; A Franklin; C Vassileva; J Li; M Simons; F W Sellke Journal: Circulation Date: 1998-11-10 Impact factor: 29.690
Authors: Michael P Robich; Robert M Osipov; Louis M Chu; Jun Feng; Thomas A Burgess; Shizu Oyamada; Richard T Clements; Roger J Laham; Frank W Sellke Journal: J Am Coll Surg Date: 2010-08-21 Impact factor: 6.113
Authors: Shigetoshi Mieno; Munir Boodhwani; Michael P Robich; Richard T Clements; Neel R Sodha; Frank W Sellke Journal: J Card Surg Date: 2010-09 Impact factor: 1.620
Authors: Andrea Caporali; Elisabetta Pani; Anton J G Horrevoets; Nicolle Kraenkel; Atsuhiko Oikawa; Graciela B Sala-Newby; Marco Meloni; Brunella Cristofaro; Gallia Graiani; Aurelie S Leroyer; Chantal M Boulanger; Gaia Spinetti; Sung Ok Yoon; Paolo Madeddu; Costanza Emanueli Journal: Circ Res Date: 2008-06-19 Impact factor: 17.367
Authors: Munir Boodhwani; Pierre Voisine; Marc Ruel; Neel R Sodha; Jun Feng; Shu-Hua Xu; Cesario Bianchi; Frank W Sellke Journal: Eur J Cardiothorac Surg Date: 2008-01-16 Impact factor: 4.191
Authors: Giovana S Di Marco; Antoine Alam; Frédéric Dol; Pierre Corvol; Jean-Marie Gasc; Etienne Larger Journal: Mol Med Date: 2008-07-27 Impact factor: 6.354
Authors: Kathrin Rychli; Christoph Kaun; Philipp J Hohensinner; Adrian J Dorfner; Stefan Pfaffenberger; Alexander Niessner; Michael Bauer; Wolfgang Dietl; Bruno K Podesser; Gerald Maurer; Kurt Huber; Johann Wojta Journal: J Cell Mol Med Date: 2010-01 Impact factor: 5.310